Videos by Acuamark Diagnostics, Inc. in New York. Revolutionizing the global fight against cancer by developing highly accurate cancer screening blood tests for early detection.
It’s Colorectal Cancer (CRC) Awareness Month, and Acuamark is pleased to be among the innovators bringing forward new technologies to make screening and monitoring for CRC more reliable, cost-effective and accessible to all.
Acuamark’s blood-based assays target the detection of methylation patterns indicative of cancer. Methylations are among the earliest indicators of cancer. Utilizing entirely novel, straightforward and easily integrated qPCR-based methods, our technology is designed to achieve highly accurate detection results and provide a richly nuanced readout – even in the initial stages of cancer.
That’s important because CRC is one of the most widespread – but preventable – cancers, and more than 100 million Americans are eligible to be screened. Follow our progress on our website!
acuamarkdx.com
#ColorectalCancerAwarenessMonth #KnowtheFacts #GetScreened #Diagnostics #EarlyDetection
It’s Colorectal Cancer (CRC) Awareness Month, and Acuamark is pleased to be among the innovators bringing forward new technologies to make screening and monitoring for CRC more reliable, cost-effective and accessible to all. Acuamark’s blood-based assays target the detection of methylation patterns indicative of cancer. Methylations are among the earliest indicators of cancer. Utilizing entirely novel, straightforward and easily integrated qPCR-based methods, our technology is designed to achieve highly accurate detection results and provide a richly nuanced readout – even in the initial stages of cancer. That’s important because CRC is one of the most widespread – but preventable – cancers, and more than 100 million Americans are eligible to be screened. Follow our progress on our website! acuamarkdx.com #ColorectalCancerAwarenessMonth #KnowtheFacts #GetScreened #Diagnostics #EarlyDetection
It’s Colorectal Cancer (CRC) Awareness Month, and Acuamark is pleased to be among the innovators bringing forward new technologies to make screening and monitoring for CRC more reliable, cost-effective and accessible to all. Acuamark’s blood-based assays target the detection of methylation patterns indicative of cancer. Methylations are among the earliest indicators of cancer. Utilizing entirely novel, straightforward and easily integrated qPCR-based methods, our technology is designed to achieve highly accurate detection results and provide a richly nuanced readout – even in the initial stages of cancer. That’s important because CRC is one of the most widespread – but preventable – cancers, and more than 100 million Americans are eligible to be screened. Follow our progress on our website! acuamarkdx.com #ColorectalCancerAwarenessMonth #KnowtheFacts #GetScreened #Diagnostics #EarlyDetection
Get ready with us for Colorectal Cancer Awareness Month in March! Colorectal Cancer Awareness Month was established in the year 2000 with the goal to raise awareness, focus on research, support those affected by colorectal cancer and encourage health-promoting behaviors – like getting screened. At #AcuamarkDx, we understand that recurrent, accurate testing and monitoring can enable cancer detection at early stages, when treatment is most effective and affordable. That's why we're developing novel technology to make it happen. Learn more about our progress and follow our news on our website. acuamarkdx.com #ColorectalCancerAwareness #GetScreened #Diagnostics #EarlyDetection
At AcuamarkDx, we're working to "Close the Care Gap" to support this year's World Cancer Day theme. Recent data from the Kaiser Family Foundation show that Black Americans continue to face the highest cancer mortality rate, partly due to diagnosis at later stages of disease, when it's harder to treat. We're developing novel technology that detects cancer-specific methylation with a simple PCR test as part of routine primary care checkups. Our mission is to ensure everyone has access to accurate, cost-effective cancer diagnosis at the earliest stages, shifting the paradigm for patients. Learn more about World Cancer Day and follow our progress at our website. Links below in the comments. #WorldCancerDay #CloseTheCareGap #AcuamarkDx #EarlyDetection
This week, the American Cancer Society released its Cancer Facts and Figures for 2024, projecting more than 2 million new cancer cases this year for the first time ever. At AcuamarkDx, we’re responding to this important challenge by advancing our novel technology for early cancer detection and frequent recurrence monitoring. Our innovative approach detects cancer-specific DNA methylation with PCR technology, making early-cancer detection as easy as an in-clinic COVID test. We’re more motivated than ever by the latest findings and the increasing need for early detection methods that are first and foremost reliable, but also cost-effective, accessible and efficient for patients and physicians. #CancerResearch #EarlyDetection #Innovation #AcuamarkDx
According to the NIH, the costs of cancer care in the U.S. alone were estimated at an astonishing $208.9 billion in 2020. For context, these costs are comparable to: • The entire GDP of Greece. • Twice the combined budgets of the world's space agencies last year. • Double the amount committed to repairing aging roads and bridges in the 2021 U.S. Infrastructure Legislation. What's more, cancer care costs are highest in a patient's final year of life. Recurrent, accurate testing and monitoring can shift cancer diagnosis and treatment to earlier stages...when it’s more effective and less expensive. At AcuamarkDx, we’re developing innovative technology to make it happen. Learn more about our progress and follow our news on our website. Link in comments. #EarlyDetection #Cancer #HealthEquity #PublicHealth
Numbers speak volumes. At #Acuamark, we're working hard to develop accurate and cost-effective technology to make early cancer detection the new standard of primary care. Join us in advocating for proactive screenings and ensuring early cancer detection is accessible to all. #Cancer #EarlyDetection #GetScreened #CancerAwareness #Diagnostics
This Labor Day weekend, while America takes a moment to rest, we want to say thank you to our team!🌟 Your dedication, hard work, and passion are the driving force behind our mission to contribute to the global battle against cancer. Your efforts make a meaningful impact every day. Here's to you! #LaborDay #EmployeeAppreciation #CancerDiagnostics
AcuamarkDx is very pleased to be featured on a new podcast, ENMEDIA Explores. Life science business leader Dr. Giulia Kennedy, distinguished member of our Board of Directors, and our CEO Dr. Bernard Peperstraete joined the podcast to talk about cracking early cancer detection. Tune in to explore the challenges in today's cancer diagnostics landscape, understand the profound impact of affordable and reliable early diagnostics on public health and health equity, and discover how AcuamarkDx is innovating in this space. Listen to the full episode for more. Links in comments. #Cancer #earlydetection #healthcare #healthequity
Hear from AcuamarkDx CEO and President @Bernard-Peperstraete as he talks about who we are and what makes us different in the cancer detection space. Interested in learning more? Take a deep dive into our novel technology at AcuamarkDx.com. #cancerdet...
Hear from AcuamarkDx CEO and President @Bernard-Peperstraete as he talks about who we are and what makes us different in the cancer detection space.
Interested in learning more? Take a deep dive into our novel technology at AcuamarkDx.com. #cancerdetection #cancerscreening
National Breast Cancer Awareness Month
Did you know breast cancer is the second leading cause of cancer deaths in women, often with little to no symptoms? In recognition of Breast Cancer Awareness Month, we want to ensure you know the importance of getting screened early. #breastcancer #cancerawareness #breastcancerawarenessmonth #cancerresearch
Discover more at https://bit.ly/38Ahgpj.